Idenix Pharma (IDIX) Resumes Trading, Down 24%
Idenix Pharmaceuticals (Nasdaq: IDIX) resumes trading, now down 24 percent early.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cliffs Natural Resources (CLF) halted with news pending
- Tootsie Roll Industries, Inc. (TR) Halted, News Pending
- Rockwell Medical Technologies (RMTI) Receives FDA Approval of Triferic
Create E-mail Alert Related CategoriesTrading Halts
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!